NIH-funded research R01 grant

Understanding how bird flu viruses become highly dangerous

Official title: Unravelling highly pathogenic influenza virus emergence

Funded at Erasmus Medical Center · NIH-10896206 · Data updated 2026-11-12

This study looks at how certain bird viruses can change and become more dangerous, which is important for keeping both birds and people safe from illness, and it aims to help us understand and stop future outbreaks.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionErasmus Medical Center
NIH-funded
Lab location1 site (Rotterdam, NETHERLANDS)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$473,525
NIH project number5R01AI177487-02
Project IDNIH-10896206 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for benefiting from this research include poultry farmers, veterinarians, and wildlife conservationists who are directly impacted by avian influenza.

Less likely to help

Patients who are not involved in poultry farming or wildlife management may not receive direct benefits from this research.

What this research studies

This research investigates the emergence of highly pathogenic avian influenza viruses (HPAIVs), which pose significant threats to poultry, wildlife, and human health. The study focuses on how low pathogenic avian influenza viruses (LPAIVs) can evolve into HPAIVs through genetic changes during replication. By examining the molecular mechanisms behind this transition, researchers aim to predict and prevent future outbreaks. The research involves analyzing viral genome changes and their effects on disease severity in different bird species.

Why it matters

Potential benefit: If successful, this research could lead to better prevention and control strategies for avian influenza outbreaks, protecting both animal and human health.

How similar studies have gone: Previous research has shown success in understanding viral evolution and emergence, but the specific mechanisms of HPAIV emergence remain an area of ongoing investigation.

Where this research is happening

  • Erasmus Medical Center
    Rotterdam, Netherlands
    Active

Researchers

  • Principal investigator: Richard, Mathilde — Erasmus Medical Center
  • Study coordinator: Richard, Mathilde

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.